Richard L Huganir

Title: Richard L. Huganir: Innovator in Neurodevelopmental Disorders

Introduction

Richard L. Huganir is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of neurodevelopmental disorders through his innovative research and patents. With a total of 4 patents, Huganir's work focuses on understanding and treating complex neurological conditions.

Latest Patents

Huganir's latest patents include groundbreaking methods for modulating SYNGAP, which involve administering agents that can effectively treat neurodevelopmental disorders. This method aims to modulate the expression of various isoforms of synaptic GTPase-activating protein (SynGAP). Another notable patent is a method for identifying compounds that affect ionotropic glutamate receptor aggregation. This method provides a way to identify compounds, such as long pentraxin polypeptides, that influence the aggregation of AMPA receptors, specifically GluR1, GluR2, and GluR3 receptor subunits.

Career Highlights

Huganir is affiliated with Johns Hopkins University, where he has been instrumental in advancing research in neurobiology. His work has not only contributed to academic knowledge but has also paved the way for potential therapeutic applications in treating neurodevelopmental disorders.

Collaborations

Huganir has collaborated with notable colleagues, including Hualing Dong and Jee Hae Kim, to further enhance the impact of his research. These collaborations have fostered a rich environment for innovation and discovery in the field.

Conclusion

Richard L. Huganir's contributions to the field of neurodevelopmental disorders through his patents and research at Johns Hopkins University highlight his role as a leading inventor. His innovative methods and collaborative efforts continue to push the boundaries of understanding and treating complex neurological conditions.